Skip to content

For research and pharmaceutical organizations only. No consumer sales.

Solenyx Logo
Portfolio

Oncology API portfolio

A therapeutic-area view of Solenyx anticancer APIs: searchable catalogue, class hubs, and a clear path to quotation and documentation — without fictional clinical programs.

All oncology

63

catalogue APIs

6

therapeutic classes

CAS

identity on every row

Quote

project-scoped supply

How to use this portfolio

Oncology on this site means anticancer active pharmaceutical ingredients — kinase inhibitors, endocrine agents, platinums, antimetabolites, taxanes/cytotoxics and supportive-care molecules — published with CAS numbers for buyer identification.

We do not publish fictional discovery-to-clinic program maps. If you need development or custom synthesis beyond the catalogue, request a quote with the molecule name and intended use.

Portfolio by class

Each class page lists members with CAS. The landing-page catalogue searches across all classes.

ClassEntriesStart here
Kinase Inhibitors18/oncology/kinase-inhibitors
Hormone and Endocrine Agents8/oncology/hormone-endocrine
Platinum and Alkylating Agents10/oncology/platinum-alkylating
Antimetabolites10/oncology/antimetabolites
Taxanes and Cytotoxics11/oncology/taxanes-cytotoxics
Supportive and Other Oncology APIs6/oncology/supportive-other

Figures are indicative industry-typical values. Lot- and project-specific data appear on the quotation and certificate of analysis.

From catalogue to quotation

01

Find the API

Search /oncology#catalogue by name or CAS, or open the matching class hub.

02

State grade and use

Share research vs. GMP intent, salt/form, pack size and any pharmacopoeial or customer specification.

03

Documentation scope

Agree COA fields, impurity needs and whether Oncology Reference Standards are required in parallel.

04

Confirm supply

Receive a project-specific quotation — catalogue listing alone is not a stock commitment.

What buyers typically request

  • CAS-confirmed identity and salt/form
  • Certificate of analysis for the agreed grade
  • Impurity or reference-standard cross-reference when needed
  • Indicative lead time and packaging
  • Technical contact for specification questions

Frequently asked questions

The former illustrative pipeline was replaced by this portfolio. We publish real catalogue APIs, not fictional clinical assets.

Next step

Ready to specify this for your program?

Share sequence, scale and documentation needs. We reply with indicative specs and a project-specific quotation.